T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin ' s Lymphoma (NHL)

Conditions: B-Cell Non-Hodgkin ' s Lymphoma (NHL); Lymphoma, Non-Hodgkins; Lymphomas Non-Hodgkin ' s B-Cell; Non-Hodgkin Lymphoma; Non-Hodgkin ' s Lymphoma; Large B-Cell Lymphoma; Lymphoma, Non-Hodgkin ' s, Adult; Lymphoma; Refractory Non-Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma; Lymphoma, Non-Hodgkin; HIV Associated Lymphoma; CNS Lymphoma; High-grade B-cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma Interventions: Biological: EB103 Sponsors: Estrella Biopharma, Inc.; Eureka Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials